New York State Common Retirement Fund Cyteir Therapeutics, Inc. Transaction History

New York State Common Retirement Fund

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 04, 2022	SELL	$1.62 - $4.4 $9,378 - $25,471	-5,789 Reduced 96.84%	189 $1,000
Q1 2022 May 05, 2022	BUY	$3.39 - $10.51 $23 - $73	7 Added 0.12%	5,978 $23,000
Q4 2021 Feb 02, 2022	BUY	$9.83 - $19.21 $58,694 - $114,702	5,971 New	5,971 $68,000

2.47M

Ticker CYT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,413,400
Market Cap $107M
Description
Cyteir Therapeutics, Inc., a clinical-stage biotechnology company, develops and commercializes the next-generation of precision oncology medicines. Its lead product CYT-0851, a novel, oral, once-daily, small molecule drug candidate that is in Phase I/II clinical trial for monotherapy in solid tumors and hematologic malignancies, as well as for c...

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

Stay updated on New York State Common Retirement Fund with notifications on news.